11 results
Keyword Bromazepam ABC Remove keyword
Categories
Veterinary Remove Veterinary filter
-
List item
Veterinary medicine European public assessment report (EPAR): Osurnia
betamethasone acetate, terbinafine, florfenicol, Dogs
Date of authorisation: 31/07/2014, Revision: 10, Authorised, Last updated: 14/01/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Aftovaxpur DOE
Maximum three of the following purified, inactivated foot-and-mouth disease virus strains: O1 Manisa ≥ 6 PD50*; O1 BFS ≥ 6 PD50*; O Taiwan 3/97 ≥ 6 PD50*; A22 Iraq ≥ 6 PD50*; A24 Cruzeiro ≥ 6 PD50*; A Turkey 14/98 ≥ 6 PD50*; Asia 1 Shamir ≥ 6 PD50*; SAT2 Saudi Arabia ≥ 6 PD50*; * PD50 – 50% protective dose in cattle as described in Ph. Eur. monograph 0063., Pigs, Cattle, Sheep
Date of authorisation: 15/07/2013,
Date of refusal: 16/05/2013, Revision: 8, Authorised, Last updated: 27/03/2020 -
List item
Veterinary medicine European public assessment report (EPAR): Clevor
ropinirole hydrochloride, Dogs
Date of authorisation: 13/04/2018, Revision: 1, Authorised, Last updated: 07/02/2019 -
List item
Veterinary medicine European public assessment report (EPAR): Ibaflin
ibafloxacin, Dogs, Cats
Date of authorisation: 13/06/2000, Revision: 7, Withdrawn, Last updated: 10/07/2013 -
List item
Withdrawn application: Somnena
buprenorphine, date of withdrawal: 29/01/2016, Initial authorisation, Last updated: 14/09/2017 -
List item
Substance and product data management services
Last updated: 22/02/2021 -
List item
Product-information templates - Human
Last updated: 08/02/2021 -
List item
Veterinary Medicines Regulation (updated)
Last updated: 31/03/2021 -
List item
Dose review and adjustment of established veterinary antibiotics in the context summary of product characteristic (SPC) harmonisation
Last updated: 13/01/2021 -
List item
News: Committee for Veterinary Medicinal Products - focus on reducing the risk of antimicrobial resistance and strengthening quality assurance
CVMP, Last updated: 15/02/2013 -
List item
News: Recommendations for use of aminoglycosides in animals to reduce risk of antimicrobial resistance
CVMP, Last updated: 25/07/2017